JOCELYN THURM: Open Payments
NPI 1447822853 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$237 in 14 payments from 11 companies in 2025. Trend: 2023 $1,511 · 2024 $200 · 2025 $237
Food & beverage: $237
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $54 |
| Kerecis Limited | 1 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $23 |
| GENZYME CORPORATION | 1 | $18 |
| Galderma Laboratories, L.P. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $18 |
| Botanix SB Inc | 1 | $16 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $14 |
| UCB, Inc. | 1 | $14 |
Products named: RINVOQ, DUPIXENT, Kerecis SurgiClose, TREMFYA, SKYRIZI, SOFDRA, Cabtreo, Bimzelx.
Industry payments across NY — which companies pay providers there.
